Who is making monkeypox vaccine? This question has been on the minds of many as the world grapples with the recent outbreak of monkeypox. The development and production of vaccines are critical in controlling the spread of this virus, and understanding the key players involved can provide insight into the global response to this health crisis.
The monkeypox vaccine market is a competitive landscape with several pharmaceutical companies and research institutions actively involved in the development and production of vaccines. One of the leading companies in this field is Bavarian Nordic, a Danish biotechnology company that has been at the forefront of monkeypox vaccine research for over two decades.
Bavarian Nordic’s monkeypox vaccine, known as Imvanex, is a live-attenuated vaccine that has been approved for use in Europe and the United States. The company has a strong track record in vaccine development, having previously developed a smallpox vaccine that has been used in the global eradication campaign.
Another significant player in the monkeypox vaccine market is Janssen, a division of Johnson & Johnson. Janssen’s monkeypox vaccine, known as Ad26.MO.A83, is an mRNA vaccine that has shown promising results in clinical trials. The company has been working on the vaccine since 2017 and has been actively involved in the global response to the recent outbreak.
In addition to these major players, several other companies and research institutions are also contributing to the monkeypox vaccine effort. For instance, the Centers for Disease Control and Prevention (CDC) in the United States has been working with partners to accelerate the development of a new monkeypox vaccine that can be produced quickly and at scale.
The collaboration between these organizations is crucial in the fight against monkeypox. By sharing resources, expertise, and data, they can accelerate the development and production of vaccines, ensuring that they are available to those who need them most. As the global community continues to respond to the monkeypox outbreak, the efforts of these companies and institutions will play a vital role in controlling the spread of the virus and protecting public health.
